Baxter International (NYSE: BAX) shares fell 8.38% in pre-market trading on Thursday, July 31, 2025, dropping to $25.70 from the previous close of $28.05.
The decline followed the release of Q2 2025 financial results, with adjusted EPS of $0.59 (down 13.24% year-over-year) and revenue of $2.81 billion (down 26.25% year-over-year). Both earnings and revenue came in slightly below analyst expectations.